Description
F 18 PYLARIFY RADIOPHARMACEUTICAL. BASE IDIQ CONTRACT.
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-12-30+$1,497,619= $1,497,619
- Mod P000012025-04-08-$122,696= $1,374,922
- Mod P000022026-05-21-$425,829= $949,093
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-12-30 | +$1,497,619 | $1,497,619 | F 18 PYLARIFY RADIOPHARMACEUTICAL. BASE IDIQ CONTRACT. |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-08 | −$122,696 | $1,374,922 | F 18 PYLARIFY RADIOPHARMACEUTICAL. BASE IDIQ CONTRACT. |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2026-05-21 | −$425,829 | $949,093 | F 18 PYLARIFY RADIOPHARMACEUTICAL. BASE IDIQ CONTRACT. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI YLYKVRPCTCR3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N0890 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $1,212,530 | FY2026 |
| 36C24626A0027 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26226F0313 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $180,436 | FY2026 |
| 36C25026N0655 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $721,744 | FY2026 |
| 36C26026F0298 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $469,134 | FY2026 |
| 36C25026N0531 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $559,352 | FY2026 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N1034 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,362 | FY2026 |
| 36C24626N0782 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,563 | FY2026 |
| 36C24626N0690 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $54,422 | FY2026 |
| 36C24626N0645 | SEQIRUS USA INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $167,990 | FY2026 |
| 36C24626N0644 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $24,097 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24625N0401_3600_36C24625D0023_3600 · retrieved 2026-09-26.